Japanese study questions benefit of treat-to-target statin therapy (EMPATHY)

(European Society of Cardiology) A study in Japanese patients with diabetic retinopathy has questioned the benefit of treat-to-target intensive versus standard statin therapy. The late-breaking results from the EMPATHY trial are presented today in a Hot Line LBCT Session at ESC Congress.